Medical device makers spend about 7 percent of revenue2 on research and development. With this significant investment comes the need for high-quality materials like the two that made their debut at Compamed (held in conjunction with Medica 2017) in Düsseldorf, Germany this week. The products include:
- Dow Corning QP1-33X0 Liquid Silicone Rubber, which enables faster cure at lower temperatures to provide new options for device design while also allowing faster injection speed at low injection pressure.
- Dow Corning QP1-5040 Self-Adhesive Liquid Silicone Rubber, which enables faster cure at lower temperatures to combine hard and soft components, allowing reasonable molding cycle times and is suitable for two-components and insert molding.
"With the aging population comes the need for more affordability, comfort and convenience in medical supplies, including silicone adhesives, an area where we continuously bring solutions to the market," said Marie Crane, medical materials market leader. "Dow's capability to anticipate and meet this growing demand is a testimony to our ability to translate market insight into technology developments helping customers to create new and needed products that positively impact patients' lives and their business."
Crane told Medical Product Outsourcing the new products give medtech engineers more design choices when incorporating components like electronics and sensors into finished devices.
According to Dow, the QP1-33X0 can be used for products service respiratory care, external communicating, wearable monitoring, and other medical device components. The QP1-5040
enables the combination of silicone onto resin substrates like copolyester. It can be cured at reasonable cure times at temperatures that do not deflect the copolyester components, opening new options for device design. The QP1-5040 Self-Adhesive LSR is a two-part, platinum-catalyzed medical material suited for liquid injection molding.
Gary Lord, strategic marketing director, said the liquid silicone rubbers give both designers and medtech manufacturers more opportunities to use different thermoplastics in their products. "It gives them more opportunities to do different and better things," he said. "These products address the needs of some of our customers and also allow us to look to the connected future."
"With more than 60 years of experience developing and commercializing silicone materials for medical devices, we have positioned ourselves as a trusted leader, pioneering many of today's material science solutions depended on by many," Lord continued. "As the way we prevent and treat disease continues to evolve, we will continue to work to inspire ourselves and others to collectively develop the best solutions for the future, including the Internet of Medical Things."
Dow Medical Solutions, a business of DowDuPont Specialty Products Division, designs differentiated solutions that help address some of the most pressing medical challenges. The business develops medical-grade elastomers, adhesives, and coatings to facilitate the fabrication and attachment of a range of medical and prosthetic devices.
DowDuPont Specialty Products, a division of DowDuPont, is a global innovation leader with technology-based materials, ingredients, and solutions that help transform industries and everyday life. Its employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, building and construction, health and wellness, food and worker safety. DowDuPont intends to separate the Specialty Products Division into an independent, publicly traded company.
DowDuPont Specialty Products is exhibiting at Compamed in Hall 8a, Stand M27, and Medica in Hall 15, Stand A23.
1. Becker's Hospital Review, 10 medical device trends for 2017, 2017.
2. Modern Healthcare, Doctor supply growing but not enough to meet projected demand, 2015.